Irritable Bowel Syndrome
‘Validation, empathy, good communication’ key to minimize gaslighting in GI care
Gaslighting occurs in a relationship when one person is made to feel manipulated and questions their reality. Medical gaslighting takes place when a patient’s concerns about their health are dismissed, minimized or they do not feel heard.
Power dynamics in patient-provider relationship offer ‘fertile arena for gaslighting’
The word “gaslighting” has taken on a life of its own in recent years, being used in the context of interpersonal relationships, political discourse and online chatter.
Sport performance anxiety, gastrointestinal symptoms linked in college athletes
WASHINGTON — College athletes frequently reported irritable bowel syndrome and gastrointestinal distress, which were linked to sports performance anxiety and fear of food, according to a poster presented here.
Patients with COVID-19 experience GI symptoms more frequently than noninfected controls
Hospitalized patients with COVID-19 had a “modest increased risk” for long-term gastrointestinal symptoms and irritable bowel syndrome compared with control patients, according to research published in Gut.
GI advocacy group kicks off #YouandIBS campaign for IBS Awareness Month
Despite affecting nearly 10% of the population, irritable bowel syndrome remains highly stigmatized. During IBS Awareness Month, a gastrointestinal disease advocacy group has launched the #YouandIBS campaign to confront this stigma head on.
Acupuncture may improve abdominal pain in IBS-D
Specific and nonspecific acupoint acupuncture improved symptoms of diarrhea among a small subset of patients with irritable bowel syndrome, according to results from a pilot study reported in JAMA Network Open.
Q&A: Gravity’s role in IBS pathogenesis, symptoms: A new hypothesis
Irritable bowel syndrome may result from ineffective anatomical, physiological and neuropsychological gravity-management systems, a researcher theorized in an article published in The American Journal of Gastroenterology.
AbbVie submits sNDA for functional constipation treatment in pediatric patients
AbbVie announced that it has submitted a supplemental new drug application for Linzess for the treatment of functional constipation in patients aged 6 to 17 years, according to a press release.
Daily plecanatide boosts bowel movement in chronic idiopathic constipation, IBS-C
CHARLOTTE, N.C. — Once daily plecanatide effectively relieved symptoms in patients of varying age with chronic idiopathic constipation and irritable bowel syndrome-constipation, according to a poster at the ACG Annual Scientific Meeting.
Daily Xifaxan improves fecal urgency, stool consistency in adults with IBS-D
CHARLOTTE, N.C. — Daily treatment with Xifaxan over 2 weeks improved stool consistency and fecal urgency in adults with irritable bowel syndrome-diarrhea, according to a poster at the ACG Annual Scientific Meeting.